Federation des caisses Desjardins du Quebec’s Meridian Bioscience Inc VIVO Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-10,528	Closed	-$89.5K	–	2301
2020 Q1	$89.5K	Buy	10,528 +6,076	+136%	+$51.2K	﹤0.01%	1076
2019 Q4	$43.4K	Buy	+4,452	New	+$41.8K	﹤0.01%	1554
2019 Q3	–	Sell	-500	Closed	-$5.94K	–	2352
2019 Q2	$5.94K	Buy	+500	New	+$6.02K	﹤0.01%	1962

Other funds holding VIVO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's VIVO Position: Q2 2020 in Review

Federation des caisses Desjardins du Quebec sold out of Meridian Bioscience Inc (VIVO) in Q2 2020, closing a stake of 10,528 shares — an estimated $89.5K sold.

Federation des caisses Desjardins du Quebec first reported a position in VIVO in Q2 2019 and held it in 3 quarters. The position peaked at $89.5K in Q1 2020. 191 funds tracked by Wall St. Rank hold VIVO as of Q2 2020.

Federation des caisses Desjardins du Quebec reported no remaining Meridian Bioscience Inc position as of Q2 2020 after selling out during the quarter.
Federation des caisses Desjardins du Quebec sold 10,528 Meridian Bioscience Inc shares in Q2 2020, an estimated $89.5K.
Federation des caisses Desjardins du Quebec first reported a position in Meridian Bioscience Inc in Q2 2019 and held it in 3 quarters.
Federation des caisses Desjardins du Quebec's Meridian Bioscience Inc position peaked at $89.5K in Q1 2020.
191 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q2 2020.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q2 2020, filed 30 Aug 2024.